MedTrace Logo

Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions

NCT03068988 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-09-07

No results posted yet for this study

Summary

The prospective randomized clinical study investigating the effect of mesenchymal stem cells on tendon healing. The objective of the study is to demonstrate the effect of concentrated bone marrow stem cells ( MSCs ) to the healing of sutured tendon of the supraspinatus muscle in comparison to the same procedure performed without MSCs. We have postulated the hypothesis that MSCs enhance the healing of the sutured supraspinatus tendon to its humeral footprint.

Conditions

  • Rotator Cuff Tear

Interventions

BIOLOGICAL

mesenchymal stem cells

mesenchymal stem cells concentrate into the supraspinatus footprint during the surgery

PROCEDURE

without mesenchymal stem cells

rotator cuff surgery without mesenchymal stem cells

Sponsors & Collaborators

  • Hospital Znojmo

    lead OTHER

Principal Investigators

  • Petr Šmíd, Dr. · General Hospital Znojmo, Czech Republic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2014-12-31
Completion
2021-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03068988 on ClinicalTrials.gov